![Heidi Hagen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Heidi Hagen
Directeur/Membre du Conseil chez
VERICEL CORPORATION
Fortune : 2 M $ au 30/06/2026
Profil
Heidi M.
Hagen is the founder of Vineti, Inc. Current jobs include Independent Director at Vericel Corp.
since 2013, Director at Obsidian Therapeutics, Inc., and Independent Director at A-Alpha Bio, Inc. since 2023.
Former jobs include Independent Director at Alaunos Therapeutics, Inc. in 2021, Director at Lykan Biosciences LLC, Senior Vice President-Operations at Dendreon Corp.
from 2002 to 2012, Chief Operating & Commercial Officer at ZappRx, Inc. in 2015, Global Chief Operating Officer at SOTIO LLC from 2013 to 2014, Chief Technical Officer at Sonoma Biotherapeutics, Inc., and Global Chief Operating Officer at SOTIO Biotech as.
Education includes undergraduate degree in 1990, graduate degree in 1993, and MBA in 2001 from the University of Washington.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VERICEL CORPORATION 0,07% | 29/04/2026 | 35 050 ( 0,07% ) | 2 M $ | 30/06/2026 |
Postes actifs de Heidi Hagen
| Sociétés | Poste | Début |
|---|---|---|
| VERICEL CORPORATION | Directeur/Membre du Conseil | 23/08/2013 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Directeur/Membre du Conseil | - |
A-Alpha Bio, Inc.
 A-Alpha Bio, Inc. Packaged SoftwareTechnology Services Develops a synthetic biology platform to aid in the development of drugs | Directeur/Membre du Conseil | 27/06/2023 |
Anciens postes connus de Heidi Hagen
| Sociétés | Poste | Fin |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Directeur Général | 30/08/2021 |
Vineti, Inc.
 Vineti, Inc. Packaged SoftwareTechnology Services Develops a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies | Fondateur | 01/02/2021 |
ZappRx, Inc.
 ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services Offers communication related services to pharmaceutical & healthcare providers | Directeur des opérations | 01/06/2015 |
Sotio LLC
 Sotio LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops active cellular immunotherapy dendritic cells for the treatment of cancer and autoimmune diseases | Directeur des opérations | 01/04/2014 |
| DENDREON CORPORATION | Directeur des opérations | 01/05/2012 |
Formation de Heidi Hagen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Vericel Corp.
 Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
 Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
ZappRx, Inc.
ZappRx, Inc. Miscellaneous Commercial ServicesCommercial Services Offers communication related services to pharmaceutical & healthcare providers | Commercial Services |
Sotio LLC
Sotio LLC BiotechnologyHealth Technology Operates as a biotechnology company that develops active cellular immunotherapy dendritic cells for the treatment of cancer and autoimmune diseases | Health Technology |
Vineti, Inc.
Vineti, Inc. Packaged SoftwareTechnology Services Develops a commercial cloud-based platform that expands patient access to life-saving cells and gene therapies | Technology Services |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
A-Alpha Bio, Inc.
A-Alpha Bio, Inc. Packaged SoftwareTechnology Services Develops a synthetic biology platform to aid in the development of drugs | Technology Services |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in research, development and manufacturing cell and genetic therapy for autoimmune and degenerative diseases | Health Technology |
Lykan Biosciences LLC | |
Sotio Biotech AS
 Sotio Biotech AS BiotechnologyHealth Technology Develops potent immunotherapies | Health Technology |
